<参考文献> https://t.co/TlUSBhisoG https://t.co/ZIOL9vONSd https://t.co/FCeDxAQR4G https://t.co/OsBd7QIUz9 ※引用記事先や引用ツイートツリー先の参考文献も併せてご参照下さい。 ※COIはありません。
Treatment of hypertension in patients 80 years of age or older.
Mentions
Extended reach
Total likes
Video views
Mentions per month
Dec 2010 – Aug 2025Where it's discussed
-
X / Twitter61 posts
-
News11 articles
-
Blogs11 articles
-
YouTube4 videos
-
Bluesky2 posts
-
Facebook2 posts
AI synopsis
What people are saying
The discussions emphasize the significance of the HYVET trial and other studies showing benefits of antihypertensive therapy in patients over 80, with phrases like 'beneficial,' 'significant reductions,' and 'time to use this more' reflecting strong support. The tone is confident and data-driven, highlighting how research translates into practice, which underscores the high interest and impact recognized in the social discussions.
Most social discussions support the positive outcomes of treating hypertension in the elderly, citing the HYVET study as strong evidence.
Posts show high interest, referencing specific trials, medication details, and clinical implications, indicating active engagement.
Many discussions include mentions of research data, trials, and clinical practice updates, demonstrating deep involvement.
The substantial focus on evidence-based results and their influence on treatment guidelines indicates high perceived impact.
Abstract in brief
- The study investigated whether treating high blood pressure in people aged 80 and older reduces the risk of serious health issues like stroke and death.
- Patients treated with blood pressure medication (indapamide and sometimes perindopril) had significant reductions in strokes, cardiovascular deaths, and overall death rates compared to those who did not receive medication.
- The findings suggest that antihypertensive therapy is beneficial for those over 80, as it lowers the risk of strokes, heart failure, and death, with fewer serious side effects reported in the treatment group.]
Top posts
Most liked on X and Bluesky80歳以上の高齢世代の血圧治療のベネフィットを示す研究の例⬇️ https://t.co/Ffx6xSuF6c
HYVET Trial Is treatment of hypertension in those 80 years or older beneficial in reducing stroke risk? Check out the attached graphic by @arknapke How do these results impact your clinical practice? Study: https://t.co/xckGOeXEQk @NEJM #CardioTwitter #TBT #TwitteRx https://t.co/nqFydNz7GO
Le traitement antihypertenseur diminue après 80 ans de 21 % le risque de décès, de 30 % celui d’AVC et de 64 % le risque d’insuffisance cardiaque. https://t.co/pKEWcznkmP
HYVET Study 高齢者にもしっかり降圧することには意味がある。 Treatment of Hypertension in Patients 80 Years of Age or Older | NEJM https://t.co/zxDb3HtboR
高齢者の高血圧は元気な高齢者と要介護の高齢者は分けて考えるべき。元気な高齢者での降圧薬の効果は明らか https://t.co/EVZFZRPDfQ
All mentions
Role of Diuretics in Managing Heart Failure with Congestion
Professor Wilfried Mullens discusses the vital role of diuretics in treating heart failure patients experiencing congestion. The ADVOR study compares acetazolamide to placebo, highlighting the challenges and…
Optimal Blood Pressure for Your Age and Cardiovascular Health
This video explores the ideal blood pressure levels for your age, highlighting the risks of high blood pressure and silent hypertension. Dr. Andr Wambier discusses three key pressures to monitor and introduces a simple…
Managing Hypertension in Frail Older Adults Effectively
This video reviews evidence on blood pressure control in older, frail patients, highlighting the balance between reducing cardiovascular events and potential risks like kidney problems. It emphasizes personalized…
Managing Hypertension in Older Adults for Cardiovascular Risk Reduction
Remember the art of checking BP. Home monitoring is preferred. Target BP is less than 140/90, adjusted for age and CV risk. Treatment of hypertension in patients 80+ reduces stroke, CV death, and overall mortality.
RT @YujiY0402: 80歳以上の高齢世代の血圧治療のベネフィットを示す研究の例⬇️ https://t.co/Ffx6xSuF6c
RT @YujiY0402: 80歳以上の高齢世代の血圧治療のベネフィットを示す研究の例⬇️ https://t.co/Ffx6xSuF6c
RT @YujiY0402: 80歳以上の高齢世代の血圧治療のベネフィットを示す研究の例⬇️ https://t.co/Ffx6xSuF6c
RT @YujiY0402: 80歳以上の高齢世代の血圧治療のベネフィットを示す研究の例⬇️ https://t.co/Ffx6xSuF6c
RT @YujiY0402: 80歳以上の高齢世代の血圧治療のベネフィットを示す研究の例⬇️ https://t.co/Ffx6xSuF6c
80歳以上の高齢世代の血圧治療のベネフィットを示す研究の例⬇️ https://t.co/Ffx6xSuF6c
RT @nnago: 高齢者の高血圧は元気な高齢者と要介護の高齢者は分けて考えるべき。元気な高齢者での降圧薬の効果は明らか https://t.co/EVZFZRPDfQ
高齢者の高血圧は元気な高齢者と要介護の高齢者は分けて考えるべき。元気な高齢者での降圧薬の効果は明らか https://t.co/EVZFZRPDfQ
HYVET2008 Diuretic in elderly Indapamide 1.5mg slow release +/- ACEi Goal : 150/80 https://t.co/OqpMyhIFsv https://t.co/mPahQVsttB
HYVET2008 Diuretic in elderly Indapamide 1.5mg slow release +/- ACEi Goal : 150/80 https://t.co/OqpMyhIFsv https://t.co/mPahQVsttB
@hvanspall @HeartOTXHeartMD @mmamas1973 @SantosGallegoMD @AndrewJSauer @AnastasiaSMihai @biljana_parapid @docmaltese @AmarPut @krychtiukmd @vass_vassiliou @avolgman Indapamide https://t.co/880dF8FJJC https://t.co/DIAH80FDBw
@DrKathlWild @DrKGregorevic And significant benefits even on total mortality in people over 80 in ADVANCE: https://t.co/d9sgR4UchF But sure, I think carefully as frailty advances and goals change.
RT @S96405539: <参考文献> https://t.co/TlUSBhisoG https://t.co/ZIOL9vONSd https://t.co/FCeDxAQR4G https://t.co/OsBd7QIUz9 ※引用記事先や引用ツイートツリー先の参考文…
RT @S96405539: <参考文献> https://t.co/TlUSBhisoG https://t.co/ZIOL9vONSd https://t.co/FCeDxAQR4G https://t.co/OsBd7QIUz9 ※引用記事先や引用ツイートツリー先の参考文…
RT @S96405539: <参考文献> https://t.co/TlUSBhisoG https://t.co/ZIOL9vONSd https://t.co/FCeDxAQR4G https://t.co/OsBd7QIUz9 ※引用記事先や引用ツイートツリー先の参考文…
RT @S96405539: <参考文献> https://t.co/TlUSBhisoG https://t.co/ZIOL9vONSd https://t.co/FCeDxAQR4G https://t.co/OsBd7QIUz9 ※引用記事先や引用ツイートツリー先の参考文…
RT @S96405539: <参考文献> https://t.co/TlUSBhisoG https://t.co/ZIOL9vONSd https://t.co/FCeDxAQR4G https://t.co/OsBd7QIUz9 ※引用記事先や引用ツイートツリー先の参考文…
RT @S96405539: <参考文献> https://t.co/TlUSBhisoG https://t.co/ZIOL9vONSd https://t.co/FCeDxAQR4G https://t.co/OsBd7QIUz9 ※引用記事先や引用ツイートツリー先の参考文…
RT @S96405539: <参考文献> https://t.co/TlUSBhisoG https://t.co/ZIOL9vONSd https://t.co/FCeDxAQR4G https://t.co/OsBd7QIUz9 ※引用記事先や引用ツイートツリー先の参考文…
RT @S96405539: <参考文献> https://t.co/TlUSBhisoG https://t.co/ZIOL9vONSd https://t.co/FCeDxAQR4G https://t.co/OsBd7QIUz9 ※引用記事先や引用ツイートツリー先の参考文…
RT @S96405539: <参考文献> https://t.co/TlUSBhisoG https://t.co/ZIOL9vONSd https://t.co/FCeDxAQR4G https://t.co/OsBd7QIUz9 ※引用記事先や引用ツイートツリー先の参考文…
RT @S96405539: <参考文献> https://t.co/TlUSBhisoG https://t.co/ZIOL9vONSd https://t.co/FCeDxAQR4G https://t.co/OsBd7QIUz9 ※引用記事先や引用ツイートツリー先の参考文…
RT @S96405539: <参考文献> https://t.co/TlUSBhisoG https://t.co/ZIOL9vONSd https://t.co/FCeDxAQR4G https://t.co/OsBd7QIUz9 ※引用記事先や引用ツイートツリー先の参考文…
RT @S96405539: <参考文献> https://t.co/TlUSBhisoG https://t.co/ZIOL9vONSd https://t.co/FCeDxAQR4G https://t.co/OsBd7QIUz9 ※引用記事先や引用ツイートツリー先の参考文…
RT @S96405539: <参考文献> https://t.co/TlUSBhisoG https://t.co/ZIOL9vONSd https://t.co/FCeDxAQR4G https://t.co/OsBd7QIUz9 ※引用記事先や引用ツイートツリー先の参考文…
RT @S96405539: <参考文献> https://t.co/TlUSBhisoG https://t.co/ZIOL9vONSd https://t.co/FCeDxAQR4G https://t.co/OsBd7QIUz9 ※引用記事先や引用ツイートツリー先の参考文…
RT @S96405539: <参考文献> https://t.co/TlUSBhisoG https://t.co/ZIOL9vONSd https://t.co/FCeDxAQR4G https://t.co/OsBd7QIUz9 ※引用記事先や引用ツイートツリー先の参考文…
RT @S96405539: <参考文献> https://t.co/TlUSBhisoG https://t.co/ZIOL9vONSd https://t.co/FCeDxAQR4G https://t.co/OsBd7QIUz9 ※引用記事先や引用ツイートツリー先の参考文…
RT @S96405539: <参考文献> https://t.co/TlUSBhisoG https://t.co/ZIOL9vONSd https://t.co/FCeDxAQR4G https://t.co/OsBd7QIUz9 ※引用記事先や引用ツイートツリー先の参考文…
RT @S96405539: <参考文献> https://t.co/TlUSBhisoG https://t.co/ZIOL9vONSd https://t.co/FCeDxAQR4G https://t.co/OsBd7QIUz9 ※引用記事先や引用ツイートツリー先の参考文…
RT @S96405539: <参考文献> https://t.co/TlUSBhisoG https://t.co/ZIOL9vONSd https://t.co/FCeDxAQR4G https://t.co/OsBd7QIUz9 ※引用記事先や引用ツイートツリー先の参考文…
RT @S96405539: <参考文献> https://t.co/TlUSBhisoG https://t.co/ZIOL9vONSd https://t.co/FCeDxAQR4G https://t.co/OsBd7QIUz9 ※引用記事先や引用ツイートツリー先の参考文…
RT @S96405539: <参考文献> https://t.co/TlUSBhisoG https://t.co/ZIOL9vONSd https://t.co/FCeDxAQR4G https://t.co/OsBd7QIUz9 ※引用記事先や引用ツイートツリー先の参考文…
RT @S96405539: <参考文献> https://t.co/TlUSBhisoG https://t.co/ZIOL9vONSd https://t.co/FCeDxAQR4G https://t.co/OsBd7QIUz9 ※引用記事先や引用ツイートツリー先の参考文…
RT @S96405539: <参考文献> https://t.co/TlUSBhisoG https://t.co/ZIOL9vONSd https://t.co/FCeDxAQR4G https://t.co/OsBd7QIUz9 ※引用記事先や引用ツイートツリー先の参考文…
<参考文献> https://t.co/TlUSBhisoG https://t.co/ZIOL9vONSd https://t.co/FCeDxAQR4G https://t.co/OsBd7QIUz9 ※引用記事先や引用ツイートツリー先の参考文献も併せてご参照下さい。 ※COIはありません。
RT @toki_wo_koe: HYVET Study 高齢者にもしっかり降圧することには意味がある。 Treatment of Hypertension in Patients 80 Years of Age or Older | NEJM https://t.co/zx…
HYVET Study 高齢者にもしっかり降圧することには意味がある。 Treatment of Hypertension in Patients 80 Years of Age or Older | NEJM https://t.co/zxDb3HtboR
RT @NicholasChiuMD: 7/ HYVET (2008): 80yo pts w/ sustained SBP >160 ⚖️Randomized: Diuretic indapamide vs. Placebo
7/ HYVET (2008): 80yo pts w/ sustained SBP >160 ⚖️Randomized: Diuretic indapamide vs. Placebo
高齢者の [高血圧治療] 最新GL:2019 https://t.co/6cYPAJLlQR https://t.co/GuMKJlMq0d https://t.co/8dlCnJnfoG [脂質異常治療] 最新GL:2017 https://t.co/lUZXJpuKY0 [糖尿病治療] 最新GL:2017 https://t.co/h8gK7cIRQ8 https://t.co/TyqDBf9eJR
RT @accpcardprn: HYVET Trial Is treatment of hypertension in those 80 years or older beneficial in reducing stroke risk? Check out the atta…
HYVET Trial Is treatment of hypertension in those 80 years or older beneficial in reducing stroke risk? Check out the attached graphic by @arknapke How do these results impact your clinical practice? Study: https://t.co/xckGOeXEQk @NEJM #CardioTwitter #TBT #TwitteRx https://t.co/nqFydNz7GO
RT @Ordoscopie: Le traitement antihypertenseur diminue après 80 ans de 21 % le risque de décès, de 30 % celui d’AVC et de 64 % le risque d’…
RT @analytics_drug: Le traitement antihypertenseur diminue après 80 ans de 21 % le risque de décès, de 30 % celui d’AVC et de 64 % le risqu…
Le traitement antihypertenseur diminue après 80 ans de 21 % le risque de décès, de 30 % celui d’AVC et de 64 % le risque d’insuffisance cardiaque. https://t.co/fmCJqg8g28
RT @Ordoscopie: Le traitement antihypertenseur diminue après 80 ans de 21 % le risque de décès, de 30 % celui d’AVC et de 64 % le risque d’…
Le traitement antihypertenseur diminue après 80 ans de 21 % le risque de décès, de 30 % celui d’AVC et de 64 % le risque d’insuffisance cardiaque. https://t.co/pKEWcznkmP
@HanCardiomd @ACCinTouch @DrNasrien @docbhardwaj @MarkDrazner @robmentz @AndrewJSauer @SantosGallegoMD @JJheart_doc @ShelleyZieroth @mmamas1973 @mvaduganathan And never forget BP lowering therapy ACEi had a 64% reduction in the rate of HF in elderly patients HYVET 2008 https://t.co/jeDdcsuixm
RT @syuichiao89: https://t.co/s1P7XXuppk この論文に「トイレットペーパー」っぽさを感じるか?もしそうなら、君は論文を読むセンスに恵まれている。
https://t.co/s1P7XXuppk この論文に「トイレットペーパー」っぽさを感じるか?もしそうなら、君は論文を読むセンスに恵まれている。
https://t.co/em5dSQEusk
RT @hswapnil: Links ALLHAT https://t.co/3tg93XEmUC SPRINT https://t.co/WrdpjhjGVm I would add that even HYVET was indapamide (more like C…
Links ALLHAT https://t.co/3tg93XEmUC SPRINT https://t.co/WrdpjhjGVm I would add that even HYVET was indapamide (more like CTD than HCTZ) https://t.co/lwfjPiGMqO #Hypertension20
Treating #HTN in the elderly matters, check out the HYVET trial from @NEJM back in 2008. Randomized patients >80 to treatment with indapamide ± perindopril and they got SBP down from ~170 to ~140 w/reduction in CVA & death. Time to use this combo more? https://t.co/eRO4N7Dvmy
RT @drjohnmorley: Treatment of Hypertension in Patients 80 Years of Age or Older | NEJM https://t.co/3A9RGfkzPp Mean systolic BP reduced to…
RT @drjohnmorley: Treatment of Hypertension in Patients 80 Years of Age or Older | NEJM https://t.co/3A9RGfkzPp Mean systolic BP reduced to…
RT @drjohnmorley: Treatment of Hypertension in Patients 80 Years of Age or Older | NEJM https://t.co/3A9RGfkzPp Mean systolic BP reduced to…
Treatment of Hypertension in Patients 80 Years of Age or Older | NEJM https://t.co/3A9RGfkzPp Mean systolic BP reduced to 140mmHg
@EvidenceMatters @BioMedCentral @AnnaNoelStorr @OriginalCoolski @dnunan79 @stephensenn @RogerJLewis E.g. HYVET study - arguably the most influential study of hypertension treatment in older people... 56% E Europe 40% China 3% W Europe/Australasia 2% N Africa!
OTOH I am uncomfortable accepting registry data over prospective RCT data. HYVET makes case for treating the elderly: http://www.nejm.org/doi/full/10.1056/NEJMoa0801369
Treatment of hypertension in patients 80 years and older: the lower the better? A meta-analysis of RCT https://pubmed.ncbi.nlm.nih.gov/20574244/?dopt=Abstract
D
NF
SS